ARTICLE | Clinical News
Liposomal Grb-2: Phase II started
February 16, 2015 8:00 AM UTC
Bio-Path began an open-label, U.S. Phase II trial to evaluate 60 and 90 mg/m 2 IV BP-100-1.01 twice weekly in 28-day cycles in combination with cytarabine in 6 patients. ...